Immunotherapy Invest Information

Companies
BioNTech Projects Ten Oncology Trials by End of 2024 Leading to First Launch in 2026 Mar 20, 2024
Companies
CytoMed Therapeutics to Showcase at Benchmark's Discovery Investor Event Nov 15, 2023
Stocks
DBV Technologies DBVT Elevated to 'Hold' by StockNews.com as Institutional Interest Surges Nov 12, 2023